Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Doximity

Stocks Hit New Highs as Jobs Data Mutes Rate Hike Talk: Stock Market Today

The Dow Jones Industrial Average and the S&P 500 posted new all-time highs after odds of a rate hike fell with a soft July jobs report.

Kiplinger

A Weak Jobs Report Boosted Bets That The Fed Won't Hike Rates In September. Stocks Climbed.

Stocks climbed again on Friday after an unexpectedly weak jobs report, which boosted bets that the Fed won't hike interest rates in September.

International Business Times

A Lesser-Known Stock Climbed More Than 100% In a Day After AI Surprise. Here's Why.

Doximity's stock more than doubled in overnight trading following its fiscal first quarter 2027 earnings report, climbing more than 130% in premarket trading before declining to about 40%.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

DOCS Stock Surges 40% Following Doximity Earnings. What Comes Next.

Doximity shares rallies on blockbuster Q1 earnings and raised guidance. Here’s how you should play DOCS shares after the quarterly print.

Barchart

Doximity shares soar 60% after CEO says its AI can outperform Anthropic

Doximity shares surged after the healthcare platform highlighted the strong performance of its clinical AI, overshadowing an earnings miss. Investors cheered its AI capabilities, positioning the company as a specialised healthcare AI player despite mixed quarterly financial results.

The Economic Times

A new medical AI study found the same flaw in OpenEvidence, OpenAI, Anthropic, and Doximity

The findings suggest healthcare AI's next challenge isn't adoption or funding—it's proving the technology can avoid dangerous omissions at the point of care.

Fortune

Doximity Q4 Earnings Call Highlights

Doximity (NYSE:DOCS) reported fiscal fourth-quarter revenue above the high end of its guidance and said it is entering what management called an “AI investment year,” with higher spending planned for artificial intelligence products even as near-term growth in the digital pharma advertising market r

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Can Waystar Still Stand Up to Rising Competition?

Companies at the intersection of cloud or AI technology and healthcare have underperformed in the last year, but some firms have compelling cases for buyers.

MarketBeat

3 New Year’s Resolution Stocks That Could Turn Around in 2026

Three companies with less-than-stellar performance records in 2025 may have the fundamentals needed to reverse course in the new year.

MarketBeat

Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings

Doximity Inc (NYSE:DOCS) reported better-than-expected earnings for the first quarter on Thursday.

Benzinga

Analyst Ratings For Doximity

Ratings for Doximity (NYSE:DOCS) were provided by 15 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

A burnout crisis is hitting doctors across the U.S. and it could spell disaster for health care

Pay increased nearly 6% in 2023—not enough to account for inflation and low reimbursements, found Doximity.

Fortune

Looking At Doximity's Recent Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bullish stance on Doximity. Looking at options history for Doximity (NYSE:DOCS) we detected 18 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022

Upgrades

Benzinga

Peering Into Doximity's Recent Short Interest

Doximity's (NYSE:DOCS) short percent of float has risen 3.27% since its last report. The company recently reported that it has 7.21 million shares sold short, which is 8.22% of all regular shares that are available for trading.

Benzinga

Looking At Doximity's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Doximity (NYSE:DOCS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Why Doximity Stock Is Falling Today

Doximity Inc (NYSE: DOCS) shares are trading lower Wednesday after the company reported financial results and issued quarterly guidance below analyst estimates.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What 5 Analyst Ratings Have To Say About Doximity

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Benzinga

Why Doximity Shares Are Trading Lower After Hours

Doximity Inc (NYSE:DOCS) reported fourth-quarter revenue growth of 40.4% year-over-year to $93.7 million, beating the consensus of $90.11 million. Adjusted net income was $44.9 million versus $24 million in 4Q21, representing a 48% margin. Adjusted EPS was $0.21, beating the consensus of $0.15. Adjusted gross margin expanded by 200 bps to 90%.…

Benzinga

Where Doximity Stands With Analysts

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Benzinga

Where Doximity Stands With Analysts

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Benzinga

Why Doximity Shares Are Trading Higher Premarket Today?

Doximity Inc (NYSE: DOCS) posted Q3 FY22 sales of $9

People

Stephanie Davis

69 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Inflation

26,157 stories

Artificial Intelligence

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.